AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests.

They are already saving lives. Wearable devices can detect cardiac issues early, triggering emergency responses and preventing complications.

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous tumor.

The new system, called scNET, combines information on gene expression at the single-cell level with information on gene interactions, enabling the identification of important biological patterns such as responses to drug treatments.

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results published in NEJM AI, a journal from the publishers of the New England Journal of Medicine.

People in the study also reported they could trust and communicate with the system, known as Therabot, to a degree that is comparable to working with a mental-health professional.

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture of Experts (MoE) architecture, multimodal data fusion capabilities, and significantly reduced training costs (over 90% lower than comparable models), DeepSeek achieves performance on par with OpenAI’s GPT-4o-mini.

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually worsen challenges related to error prevention and physician burnout, according to a new brief published in JAMA Health Forum.

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders share similarities, sometimes making a definitive diagnosis initially difficult.

Although Parkinson’s disease is a well-recognized illness, the term can refer to a variety of conditions, ranging from idiopathic Parkinson's, the most common type, to other movement disorders like multiple system atrophy Parkinsonian variant and progressive supranuclear palsy.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most likely to benefit from partial gland cryoablation, a minimally invasive procedure that treats localized prostate tumors.

Researchers found that an AI tool called Unfold AI, developed by researchers at UCLA and Avenda Health, accurately estimates prostate tumor volume and helps identify patients with a higher chance of successful treatment.